Skip to content
Search

Latest Stories

One in eight patients developed heart inflammation after hospitalisation with Covid-19

One in eight people who were hospitalized with Covid-19 between May 2020 and March 2021 were later diagnosed with myocarditis, according to major new research into the clinical long-term effects of coronavirus.

The largest study of its kind to date was led by the University of Glasgow in collaboration with NHS Greater Glasgow and Clyde (NHS GGC), and followed for one year, in real time, 159 patients after they were hospitalized with Covid-19.


The study also looked at why some patients suffer long-term ill health after hospitalization with Covid-19. Until now it has been speculated that previous underlying health conditions may be linked to the severity of post-Covid long-term effects.

However, this new study suggests that it is the severity of the infection itself which is most closely correlated to the severity of a patient’s long-Covid symptoms, rather than pre-existing health problems.

Hospitalization with Covid-19 was found to cause a number of long-term health problems.

Researchers found one in eight patients hospitalized with Covid-19 have heart inflammation, while inflammation across the body and damage to the other organs such as the kidneys was also common.

These problems clustered in individuals pointing to the overall severity of Covid-19 as being the main driver of illness. Exercise capacity and health related quality of life were markedly impaired initially after discharge from hospital and remained reduced one to two months after discharge – this was especially the case in patients with heart inflammation.

During a period of 450 days after discharge from hospital, one in seven patients died or were readmitted to hospital, and two in three patients required NHS outpatient care.

Patients were given questionnaires on the same day they underwent blood tests and scans, before they had been given clinical results, in order to gain a true understanding of how they were feeling post hospitalisation. From these questionnaires, having been hospitalised with Covid-19 was associated with a worse health-related quality of life as well as with anxiety and depression.

Professor Colin Berry, principle investigator of the study, said: “Covid-19 is a multi-system disease, and our study shows that injury on the heart, lungs and kidneys can be seen after initial hospitalisation in scans and blood tests. These results bridge a vital knowledge gap between our current understanding of post-Covid-19 syndromes, such as Long Covid, and objective evidence of ongoing disease."

The study, ‘Multisystem, cardio-renal investigation of post-covid illness’ is published in Nature Medicine and was funded by the Scottish government’s chief scientist office, and supported by the British Heart Foundation (BHF) as part of the University of Glasgow BHF Centre of Excellence.

More For You

RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less